Thematic Investing Brings PE to the Clinical Trials Market
COVID-19 shone a light on a fragmented market. Now private equity firms are building platforms of clinical site businesses with an eye toward improving diversity.
Sectors
A Pathway to Resilience: Reshoring Shapes PE’s Manufacturing Strategy
TBM Consulting shares considerations for PE investors in manufacturing as reshoring efforts grow
PE Strikes While the Financial Services Iron Is Hot
ACG Digital Editor Carolyn Vallejo reports on recent Katten data highlighting PE's interest in financial services
As Pet Ownership Evolves, New Pockets of Opportunity Emerge
MySimplePetLab joins GrowthTV to discuss the M&A opportunity in the pet market
Wading Through the Data of M&A Forecasts
We combed through industry research and talked to three experts to get the skinny on what PE can expect for dealmaking this year
Conversational AI Gets Strategic Acquirers Talking
How corporates can look beyond the hype to identify AI targets that add real value
Divided Congress Limits Legislative Possibilities, Shifts Focus to Financial Regulators
Trade is among the areas for bipartisanship in a divided Congress, while regulatory activity ramps up and the debt ceiling looms
Tech-Enabled Services: A Bright Spot in a Dimming Deal Environment
Corporate Advisory Solutions' Michael Lamm discusses the resiliency of tech-enabled business services
When Hiring a CFO, PE Firms Refuse to Settle
Amid macroeconomic pressures, PE firms need CFOs who can turn challenges into opportunities
Without SAFE Banking Act’s Passage, What’s Next for Cannabis M&A?
Congress failed to pass the SAFE Banking Act in its lame-duck session. Burns & Levinson attorneys share what that means for dealmakers